Hiromi Nishigaki
Overview
Explore the profile of Hiromi Nishigaki including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
15
Citations
64
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Arakawa Y, Tamagawa-Mineoka R, Ueta M, Nakanishi M, Nishigaki H, Katoh N
Exp Dermatol
. 2025 Mar;
34(3):e70074.
PMID: 40066904
Ikaros, which is encoded by the Ikaros family zinc finger 1 (IKZF1) gene, is a zinc finger transcription factor. We have previously generated K5-Ikzf1-EGFP transgenic mice (Ikzf1 Tg) by introducing...
2.
Nakanishi M, Tamagawa-Mineoka R, Nishigaki H, Arakawa Y, Ohtsuka S, Katoh N
Exp Dermatol
. 2025 Feb;
34(2):e70064.
PMID: 39967561
Atopic dermatitis (AD) is a common skin disease. Although AD pathogenesis has been widely researched, inhibitory mechanisms in AD are still unclear. Sialic acid-binding immunoglobulin-like lectins (Siglecs) are a family...
3.
Ueta M, Nishigaki H, Yoshioka H, Kinoshita S, Sotozono C
Sci Rep
. 2025 Jan;
15(1):893.
PMID: 39762541
Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) are severe mucocutaneous disorders characterized by extensive tissue necrosis; they are often accompanied by severe ocular complications (SOC). The regulatory role of...
4.
Kawasaki-Nagano M, Tamagawa-Mineoka R, Kurioka T, Arakawa Y, Nakanishi M, Kishida M, et al.
Exp Dermatol
. 2024 Nov;
33(11):e70015.
PMID: 39513758
Platelet-activating factor (PAF) is an important chemical mediator in the field of inflammation, but its function in the skin is unclear. To unravel the role of PAF, we focused on...
5.
Komai S, Ueta M, Nishigaki H, Mizushima K, Naito Y, Kinoshita S, et al.
Sci Rep
. 2023 May;
13(1):7925.
PMID: 37193897
Toll-like receptor 3 (TLR3) and interferon-beta promoter stimulator-1 (IPS-1) are associated with antiviral responses to double-stranded RNA viruses and contribute to innate immunity. We previously reported that conjunctival epithelial cell...
6.
Tamagawa-Mineoka R, Ueta M, Arakawa Y, Nakanishi M, Nishigaki H, Katoh N
Exp Dermatol
. 2023 Mar;
32(5):715-717.
PMID: 36933947
No abstract available.
7.
Ueta M, Nishigaki H, Komai S, Mizushima K, Tamagawa-Mineoka R, Naito Y, et al.
Front Genet
. 2023 Jan;
13:1025539.
PMID: 36685889
We have hypothesized that different factors are involved in the severity of ACD and AD because some but not all patients with atopic dermatitis (AD) present with allergic conjunctival disease...
8.
Maruyama A, Tamagawa-Mineoka R, Nishigaki H, Masuda K, Katoh N
Medicine (Baltimore)
. 2022 Oct;
101(42):e31267.
PMID: 36281133
Background: The pathogenesis of atopic dermatitis (AD) involves various mediators, including cytokines and chemokines, which are produced by immune cells, such as dendritic cells and lymphocytes, and non-immune cells, such...
9.
Maeno M, Tamagawa-Mineoka R, Arakawa Y, Nishigaki H, Yasuike R, Masuda K, et al.
Clin Immunol
. 2022 Mar;
237:108983.
PMID: 35314361
Background: Platelets are involved in the pathomechanisms of atopic dermatitis (AD). This study aimed to elucidate the levels of platelet-related miRNAs, (miR-24 and miR-191) in the plasma of AD patients...
10.
Ueta M, Nishigaki H, Komai S, Sotozono C, Kinoshita S
Immun Inflamm Dis
. 2021 Sep;
9(4):1815-1819.
PMID: 34547828
Introduction: Some but not all patients with atopic dermatitis (AD) present with allergic conjunctival disease (ACD) including severe types such as atopic keratoconjunctivitis (AKC) with/without giant papillae. We hypothesized that...